228 related articles for article (PubMed ID: 12813461)
1. Activation of beta-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation.
Bierie B; Nozawa M; Renou JP; Shillingford JM; Morgan F; Oka T; Taketo MM; Cardiff RD; Miyoshi K; Wagner KU; Robinson GW; Hennighausen L
Oncogene; 2003 Jun; 22(25):3875-87. PubMed ID: 12813461
[TBL] [Abstract][Full Text] [Related]
2. Identification of genes differentially expressed in mouse mammary epithelium transformed by an activated beta-catenin.
Renou JP; Bierie B; Miyoshi K; Cui Y; Djiane J; Reichenstein M; Shani M; Hennighausen L
Oncogene; 2003 Jul; 22(29):4594-610. PubMed ID: 12881717
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of beta-catenin induces lesions reminiscent of prostatic intraepithelial neoplasia, but terminal squamous transdifferentiation of other secretory epithelia.
Gounari F; Signoretti S; Bronson R; Klein L; Sellers WR; Kum J; Siermann A; Taketo MM; von Boehmer H; Khazaie K
Oncogene; 2002 Jun; 21(26):4099-107. PubMed ID: 12037666
[TBL] [Abstract][Full Text] [Related]
4. Activation of beta -catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias.
Miyoshi K; Shillingford JM; Le Provost F; Gounari F; Bronson R; von Boehmer H; Taketo MM; Cardiff RD; Hennighausen L; Khazaie K
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):219-24. PubMed ID: 11773619
[TBL] [Abstract][Full Text] [Related]
5. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors.
Miyoshi K; Rosner A; Nozawa M; Byrd C; Morgan F; Landesman-Bollag E; Xu X; Seldin DC; Schmidt EV; Taketo MM; Robinson GW; Cardiff RD; Hennighausen L
Oncogene; 2002 Aug; 21(36):5548-56. PubMed ID: 12165853
[TBL] [Abstract][Full Text] [Related]
6. Squamous cell carcinoma and mammary abscess formation through squamous metaplasia in Smad4/Dpc4 conditional knockout mice.
Li W; Qiao W; Chen L; Xu X; Yang X; Li D; Li C; Brodie SG; Meguid MM; Hennighausen L; Deng CX
Development; 2003 Dec; 130(24):6143-53. PubMed ID: 14597578
[TBL] [Abstract][Full Text] [Related]
7. Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin.
Harada N; Miyoshi H; Murai N; Oshima H; Tamai Y; Oshima M; Taketo MM
Cancer Res; 2002 Apr; 62(7):1971-7. PubMed ID: 11929813
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of Apc in the mouse prostate causes prostate carcinoma.
Bruxvoort KJ; Charbonneau HM; Giambernardi TA; Goolsby JC; Qian CN; Zylstra CR; Robinson DR; Roy-Burman P; Shaw AK; Buckner-Berghuis BD; Sigler RE; Resau JH; Sullivan R; Bushman W; Williams BO
Cancer Res; 2007 Mar; 67(6):2490-6. PubMed ID: 17363566
[TBL] [Abstract][Full Text] [Related]
9. Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice.
White DE; Cardiff RD; Dedhar S; Muller WJ
Oncogene; 2001 Oct; 20(48):7064-72. PubMed ID: 11704830
[TBL] [Abstract][Full Text] [Related]
10. Lineage-specific requirements of beta-catenin in neural crest development.
Hari L; Brault V; Kléber M; Lee HY; Ille F; Leimeroth R; Paratore C; Suter U; Kemler R; Sommer L
J Cell Biol; 2002 Dec; 159(5):867-80. PubMed ID: 12473692
[TBL] [Abstract][Full Text] [Related]
11. Mammary gland specific hEGF receptor transgene expression induces neoplasia and inhibits differentiation.
Brandt R; Eisenbrandt R; Leenders F; Zschiesche W; Binas B; Juergensen C; Theuring F
Oncogene; 2000 Apr; 19(17):2129-37. PubMed ID: 10815804
[TBL] [Abstract][Full Text] [Related]
12. Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulation.
Liu BY; Kim YC; Leatherberry V; Cowin P; Alexander CM
Oncogene; 2003 Dec; 22(58):9243-53. PubMed ID: 14681683
[TBL] [Abstract][Full Text] [Related]
13. Mammary gland tissue targeted overexpression of human protease-activated receptor 1 reveals a novel link to beta-catenin stabilization.
Yin YJ; Katz V; Salah Z; Maoz M; Cohen I; Uziely B; Turm H; Grisaru-Granovsky S; Suzuki H; Bar-Shavit R
Cancer Res; 2006 May; 66(10):5224-33. PubMed ID: 16707447
[TBL] [Abstract][Full Text] [Related]
14. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.
Bhatia N; Spiegelman VS
Mol Carcinog; 2005 Apr; 42(4):213-21. PubMed ID: 15765534
[TBL] [Abstract][Full Text] [Related]
15. Transformation and morphological changes of murine L cells by transfection with a mutated form of beta-catenin.
Nagasawa Y; Miyoshi Y; Iwao K; Shinomura Y; Matsuzawa Y; Nakamura Y
Cancer Res; 1999 Aug; 59(15):3539-42. PubMed ID: 10446956
[TBL] [Abstract][Full Text] [Related]
16. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
[TBL] [Abstract][Full Text] [Related]
17. Role of endocrine, autocrine, and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice.
Lin TP; Guzman RC; Osborn RC; Thordarson G; Nandi S
Cancer Res; 1992 Aug; 52(16):4413-9. PubMed ID: 1386556
[TBL] [Abstract][Full Text] [Related]
18. Dominant-stable beta-catenin expression causes cell fate alterations and Wnt signaling antagonist expression in a murine granulosa cell tumor model.
Boerboom D; White LD; Dalle S; Courty J; Richards JS
Cancer Res; 2006 Feb; 66(4):1964-73. PubMed ID: 16488995
[TBL] [Abstract][Full Text] [Related]
19. Nuclear beta-catenin-dependent Wnt8 signaling in vegetal cells of the early sea urchin embryo regulates gastrulation and differentiation of endoderm and mesodermal cell lineages.
Wikramanayake AH; Peterson R; Chen J; Huang L; Bince JM; McClay DR; Klein WH
Genesis; 2004 Jul; 39(3):194-205. PubMed ID: 15282746
[TBL] [Abstract][Full Text] [Related]
20. Transformation of mammary epithelial cells by 3-phosphoinositide- dependent protein kinase-1 activates beta-catenin and c-Myc, and down-regulates caveolin-1.
Xie Z; Zeng X; Waldman T; Glazer RI
Cancer Res; 2003 Sep; 63(17):5370-5. PubMed ID: 14500370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
